. Author manuscript; available in PMC: 2017 Dec 1.

Published in final edited form as: Epilepsia. 2016 Oct 14;57(12):1958–1967. doi: 10.1111/epi.13577

Table 1.

Proportion of mice with and without seizures. Distribution of maximum observed Racine seizure stage.

Treatment	Group Size (n)	Seizure Observed (n, %)	No Seizure Observed (n, %)	Maximum Stage 3 (n, %)	Maximum Stage 4 (n, %)	Maximum Stage 5 (n, %)
VEH (3 × 10⁵ PFU)	25	13 (52%)	12 (48%)	0 (0%)	2 (15%)	11 (84.6)
MIN (50 mg/kg, b.i.d.)	25	8 (32%)	17 (68%)	*2 (25%)^	1 (12.5%)	5 (62.5%)
VEH (2.5 × 10⁵ PFU)	28	18 (64.3%)	10 (35.7%)	1 (5.5%)	1 (5.5%)	16 (88.9%)
MIN (50 mg/kg, q.d.)	28	18 (64.3%)	10 (35.7%)	3 (16.7%)	1 (5.5%)	14 (77.8%)
VPA (100 mg/kg, q.d.)	27	*9 (33.3%)^	18 (66.7%)	1 (14.2%)	0 (0%)	6 (85.7%)

indicates significantly different from the endpoint measurement of the VEH group in same study, p < 0.05.